InvestorsHub Logo
icon url

nsomniyak

10/22/17 1:29 PM

#40479 RE: chickpea598 #40477

I actually think the potential could be far greater than that.

If ONCS' technology can boost the effectiveness of one Merck drug, seems reasonable that it might/could also boost the performance of other drugs. I think of it as potentially the drug analog of an accelerant for fire or fracking for oil production or fertilizer for your lawn - things you add to make what is already there work better.

If that is what we have here, the value to a Merck or other BP would be enormous.
icon url

trading.jeff

10/22/17 4:15 PM

#40484 RE: chickpea598 #40477

$ONCS Punit said, a few years ago, that he prefers the licensing route. As things stand now, he'd be foolish not to play both the licensing card AND the buyout card.